Transgenic mouse models with gene mutations for APP and PSEN1 were widely used to investigate the biofluids and brain metabolome and observed significant overlap in the affected metabolic pathways identified in AD patients.26, 27, 28. This evidence concerns the gene PSEN1 and Alzheimer disease.